Skip to main content

Table 2 Final round 3 voting on ten rheumatoid arthritis–specific key performance indicators for centralized intake

From: Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis

 

Median (range) and percentage of participants voting ≥7 on 1–9 scale for each domain (n = 23 unless otherwise specified)

 

Scientific validity

Face validity

Feasibility: information availability

Importance

Likelihood of use

KPI 2: Time from RA referral receipt to referral completion for initially incomplete referrals

7 (5–8), 61 %

7 (6–8), 74 %

8 (6–8), n = 22 (64 %)

8 (7–8), 78 %

7 (6–8), 65 %

KPI 4: Percentage of RA referrals received with complete information

7 (7–8), 78 %

8 (7–8), 83 %

7 (6–8), n = 22 (59 %)

8 (7–8), n = 22 (82 %)

7 (6–8), n = 22 (68 %)

KPI 6: Waiting times for rheumatologist consultation for patients with new-onset rheumatoid arthritis

N/Aa

N/Aa

8 (8–9), n = 21 (95 %)

9 (8–9), n = 22 (100 %)

9 (9–9), n = 22 (100 %)

KPI 7: Time to disease-modifying antirheumatic drug therapy for patients with new-onset RA

N/Aa

N/Aa

7 (6–8), n = 22 (68 %)

9 (8–9), 91 %

9 (8–9), n = 22 (100 %)

KPI 8: Percentage of patients with new-onset RA with at least one visit to a rheumatologist in the first year of diagnosis

N/Aa

N/Aa

7 (6–8), n = 21 (57 %)

8 (7–9), 78 %

8 (7–8), 83 %

KPI 10: Rheumatologists per 100,000 population

N/Aa

N/Aa

7 (6–8), n = 21 (62 %)

7 (6–7), n = 22 (59 %)

7 (5–7), n = 21 (52 %)

KPI 17: Waiting times for patients with established RA

8 (8–9), 96 %

9 (8–9), 96 %

8 (7–8), n = 22 (77 %)

8 (8–9), 91 %

8 (8–9), 96 %

KPI 18: Percentage of rheumatoid arthritis patients treated with a disease-modifying antirheumatic drug during the measurement year

N/Aa

N/Aa

8 (6–9), 70 %

8 (8–9), 83 %

9 (8–9), 83 %

KPI 28: Ratio of patient flow to clinic capacity of RA teams participating in centralized intake

7 (6–8), n = 22 (73 %)

8 (7–8), n = 22 (82 %)

7 (5–8), n = 22 (55 %)

7 (7–8), 83 %

8 (7–9), n = 22 (86 %)

KPI 31: Agreement of centralized intake suspected diagnosis versus confirmed diagnosis of RA

8 (6–8), n = 21 (71 %)

8 (6–8), 74 %

7 (5–8), n = 22 (55 %)

8 (7–9), n = 22 (86 %)

8 (7–9), n = 21 (76 %)

  1. RA rheumatoid arthritis
  2. aKey performance indicators (KPIs) 6, 7, 8, 10 and 18 were harmonized with the Arthritis Alliance of Canada performance measure set for inflammatory arthritis which used a similar process for development and scientific validity and face validity were not examined again in the present study